Insights

Market Positioning Bilim Pharmaceuticals operates within the large-scale pharmaceutical manufacturing industry with a substantial revenue range of one to ten billion dollars, indicating a strong market presence and potential for high-volume supply chain opportunities.

Growth Potential The company's significant employee base of over 1,000 staff suggests ongoing expansion plans and capacity for increased production, presenting opportunities for suppliers of manufacturing equipment, logistics, and HR solutions.

Technological Stack Utilization of advanced technologies such as PHP, MySQL, and web tools indicates a digitally integrated operation, which opens doors for software, IT services, and cybersecurity solutions tailored to large pharmaceutical firms.

Competitive Landscape Similarity with competitors like Hovione and Synthon, which also have extensive staff and revenue, highlights the importance of targeted outreach to differentiate offerings and capture more market share through product innovation or cost advantages.

Funding & Growth While specific funding details are unavailable, the company's substantial revenue and industry standing imply investment readiness, making it a promising candidate for partnership or strategic alliances in R&D, distribution, or co-innovation initiatives.

Similar companies to Bilim Pharmaceuticals

Bilim Pharmaceuticals Tech Stack

Bilim Pharmaceuticals uses 8 technology products and services including MySQL, Font Awesome, Select2, and more. Explore Bilim Pharmaceuticals's tech stack below.

MySQL
Database
Font Awesome
Font Scripts
Select2
Javascript Libraries
Slider Revolution
Miscellaneous
PHP
Programming Languages
Minitab
Visualisation Software
X-Content-Type-Options
Web & Portal Technology
Microsoft IIS
Web Servers

Media & News

Bilim Pharmaceuticals's Email Address Formats

Bilim Pharmaceuticals uses at least 1 format(s):

Bilim Pharmaceuticals Email Formats	Example	Percentage
First.Last@bilimilac.com.tr	John.Doe@bilimilac.com.tr	72%
LastFirst@bilimilac.com.tr	DoeJohn@bilimilac.com.tr	20%
FLast@bilimilac.com.tr	JDoe@bilimilac.com.tr	7%
Last@bilimilac.com.tr	Doe@bilimilac.com.tr	1%

Frequently Asked Questions

What is Bilim Pharmaceuticals's official website and social media links?

Bilim Pharmaceuticals's official website is bilimilac.com.tr and has social profiles on LinkedIn.

What is Bilim Pharmaceuticals's NAICS code?

Bilim Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Bilim Pharmaceuticals have currently?

As of December 2025, Bilim Pharmaceuticals has approximately 1K employees across 4 continents, including AsiaAfricaEurope. Key team members include Finance Director: T. K.Administrative Affairs And Fleet Manager: B. C.Field Force Manager: G. Y.. Explore Bilim Pharmaceuticals's employee directory with LeadIQ.

What industry does Bilim Pharmaceuticals belong to?

Bilim Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Bilim Pharmaceuticals use?

Bilim Pharmaceuticals's tech stack includes MySQLFont AwesomeSelect2Slider RevolutionPHPMinitabX-Content-Type-OptionsMicrosoft IIS.

What is Bilim Pharmaceuticals's email format?

Bilim Pharmaceuticals's email format typically follows the pattern of First.Last@bilimilac.com.tr. Find more Bilim Pharmaceuticals email formats with LeadIQ.

When was Bilim Pharmaceuticals founded?

Bilim Pharmaceuticals was founded in 1953.

Bilim Pharmaceuticals

Q: How many employees does Bilim Pharmaceuticals have currently?

Bilim Pharmaceuticals has approximately 1K employees.

Q: What technology does Bilim Pharmaceuticals use?

Bilim Pharmaceuticals's tech stack includes Font Awesome, Windows Server, PHP, jQuery Validation Plugin, Bootstrap.

Pharmaceutical ManufacturingIstanbul, Turkey1001-5000 Employees

bilim calisanlarının biraraya geldigi , resmi olmayan paylasım platformudur.
Kurumu resmi olarak  temsil etmemektedir.























non-official sharing platform...

................................................................................................................................................................